News – Page 350
-
Business
GSK commits to HIV research
Firm will partner with US university and cancels plan to sell its share of ViiV Healthcare joint venture
-
Business
Judge refuses Freedom Industries’ bankruptcy plan
Court says $6.7m proposal from the company responsible for huge West Virginia chemical spill is inadequate
-
ResearchJellyfish skin perfect mould to cast complex nanoparticles
Hierarchical silver hybrid particles are cheap to make and have good catalytic activity
-
NewsOpiate-producing yeast raises spectre of 'home-brewed heroin'
Warnings that completion of final steps in opiate biosynthesis could be a double-edged sword
-
Business$13.8bn Danaher bid wins Pall auction
Mega-merger follows consolidation trend in lab equipment supply sector, but analysts suggest this is yet to impact pricing competition
-
Business
DuPont overcomes investor challenge
Shareholders decline to elect activist board nominees in a show of support for the current management’s strategy
-
NewsUN sets its sights on marine microplastics
Scale of the problem means no simple solutions exist to tackle plastic particles already in the world’s oceans
-
NewsUniversities bear brunt of cuts to keep Australian science running
Cuts to funding for researchers announced in budget staves off infrastructure closures
-
BusinessTrade agreement could limit access to medicines
If approved in its leaked form, the Trans-Pacific Partnership would pose barriers for generic drugs to enter the market and keep drug prices high, warns the Foundation for Aids Research
-
NewsPanel of top scientists set to advise European commission
Announcement ends uncertainty over scientific advice after chief scientific adviser post scrapped
-
Business
Injunction blocks first US biosimilar
Despite regulatory approval, Amgen is delaying sales of Sandoz’s version of filgrastim
-
ResearchGraphene-wrapped diamond ball bearings cut friction to virtually nothing
Discovery could help save energy and money, but still needs to overcome limitations in humid conditions
-
News
California demands warning labels for BPA
Despite safety evidence, the state has added BPA to its list of cancer-linked chemicals under ‘Proposition 65’
-
Business
FDA accused of violating drug company’s freedom of speech
Amarin says the regulator is stopping it from giving ‘truthful, not misleading’ information to doctors about its fatty acid drug
-
ResearchEspresso maker brews up tasty extraction
Household appliance isolates flu drug raw material from star anise while minimising pigment contamination
-
ResearchElectricity harvested from magnetic noise
Magneto–mechano–electric generator could be effective power source for wireless charging
-
NewsTory election victory heralds new science minister for UK
David Cameron’s cabinet reshuffle ushers in new faces for research and universities posts
-
Business
Alexion to buy Synageva for rare disease drugs
$8.4bn deal gives firm access to enzyme drug currently under review with US and EU regulators
-
Business
Takeda offers $2.4bn to settle diabetes litigation
Aims to settle multiple outstanding lawsuits relating to Actos (pioglitazone) and bladder cancer
-
NewsGreenhouse gas milestone exceeded
Global carbon dioxide levels have passed 400ppm for the first time, according to new data from the US